Lessons from Red Yeast Rice: Factors to Consider Regarding FDA’s Position on CBD Supplements
By Celeste D. Wheeler, James William Woodlee, and Anthony L. Young Last week, FDA posted eight warning letters issued to companies marketing … more
Insights + News
Dan Dwyer to Speak at MSU Food Law Conference
Dan Dwyer will be providing an update on FDA inspectional practices and how to deal with them at the upcoming Food Law … more
Stacy Ehrlich Joins FDLI Board
Stacy Ehrlich was invited by the Food and Drug Law Institute (FDLI) to join the Board of Directors, for a term beginning … more
FDA Issues Preventive Controls Final Rule for Human Foods
FDA announced the publication of its final rule on preventive controls for human food. This is a comprehensive revision of FDA food … more
Stacy Ehrlich to Speak at SFATA
KKB partner Stacy Ehrlich will present on “Planning for the Final Deeming Regulations” at the Smoke-Free Alternatives Trade Association’s (SFATA) 2015 annual … more
After Years of Diluted Enforcement, FDA is Giving Homeopathic Products a Closer Examination
Since 1988, FDA has allowed the marketing of homeopathic drug products for over-the-counter (OTC) use without new drug approval or compliance with … more
With New Draft Guidance, FDA Seeks to Make Prescription Drug Print Advertising Disclosures More Effective
Last week, FDA released a draft guidance document in response to requests for more specific guidelines on how risk information should be … more